Natural History of Myocardial Injury and Chamber Remodeling in Acute Myocarditis.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
07 2019
Historique:
entrez: 5 7 2019
pubmed: 5 7 2019
medline: 28 4 2020
Statut: ppublish

Résumé

Cardiovascular magnetic resonance (CMR) imaging is commonly used to diagnose acute myocarditis. However, the natural history of CMR-based tissue markers and their association with left ventricular recovery is poorly explored. We prospectively investigated the natural history of CMR-based myocardial injury and chamber remodeling over 12 months in patients with suspected acute myocarditis. One hundred patients with suspected acute myocarditis were enrolled. All underwent CMR evaluations at baseline and 12 months, inclusive of T2 and late gadolinium enhancement. Blinded quantitative analyses compared left ventricular chamber volumes, function, myocardial edema, and necrosis at each time point using predefined criteria. The predefined primary outcomes were improvement in left ventricular ejection fraction ≥10% and improvement in the indexed left ventricular end diastolic volume ≥10% at 12 months. The mean age was 39.9±14.5 years (82 male) with baseline left ventricular ejection fraction of 57.1±11.2%. A total of 72 patients (72%) showed late gadolinium enhancement at baseline with 57 (57%) having any T2 signal elevation. Left ventricular volumes and EF improved significantly at 12 months. Global late gadolinium enhancement extent dropped from 8.5±9.2% of left ventricular mass to 3.0±5.2% ( P=0.0001) with prevalence of any late gadolinium enhancement dropping to 48%. Reductions in global T2 signal ratio occurred at 12 months (1.85±0.3 to 1.56±0.2; P=0.0001) with prevalence of T2 ratio ≥2.0 dropping to 7%. Neither marker provided associations with the primary outcomes. In clinically suspected acute myocarditis, significant reductions in tissue injury markers occur during the first 12 months of convalescence. Neither the presence nor extent of the investigated CMR-based tissue injury markers were predictive of our pre-defined function or remodeling outcomes at 12 months in this referral population.

Sections du résumé

BACKGROUND
Cardiovascular magnetic resonance (CMR) imaging is commonly used to diagnose acute myocarditis. However, the natural history of CMR-based tissue markers and their association with left ventricular recovery is poorly explored. We prospectively investigated the natural history of CMR-based myocardial injury and chamber remodeling over 12 months in patients with suspected acute myocarditis.
METHODS
One hundred patients with suspected acute myocarditis were enrolled. All underwent CMR evaluations at baseline and 12 months, inclusive of T2 and late gadolinium enhancement. Blinded quantitative analyses compared left ventricular chamber volumes, function, myocardial edema, and necrosis at each time point using predefined criteria. The predefined primary outcomes were improvement in left ventricular ejection fraction ≥10% and improvement in the indexed left ventricular end diastolic volume ≥10% at 12 months.
RESULTS
The mean age was 39.9±14.5 years (82 male) with baseline left ventricular ejection fraction of 57.1±11.2%. A total of 72 patients (72%) showed late gadolinium enhancement at baseline with 57 (57%) having any T2 signal elevation. Left ventricular volumes and EF improved significantly at 12 months. Global late gadolinium enhancement extent dropped from 8.5±9.2% of left ventricular mass to 3.0±5.2% ( P=0.0001) with prevalence of any late gadolinium enhancement dropping to 48%. Reductions in global T2 signal ratio occurred at 12 months (1.85±0.3 to 1.56±0.2; P=0.0001) with prevalence of T2 ratio ≥2.0 dropping to 7%. Neither marker provided associations with the primary outcomes.
CONCLUSIONS
In clinically suspected acute myocarditis, significant reductions in tissue injury markers occur during the first 12 months of convalescence. Neither the presence nor extent of the investigated CMR-based tissue injury markers were predictive of our pre-defined function or remodeling outcomes at 12 months in this referral population.

Identifiants

pubmed: 31269814
doi: 10.1161/CIRCIMAGING.118.008614
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008614

Auteurs

James A White (JA)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).
Department of Diagnostic Imaging, Cumming School of Medicine, University of Calgary, Canada (J.A.W., C.P.L.).
Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Canada (J.A.W., B.H., A.G.H.).
Department of Community Health Sciences, University of Calgary, Canada (M.P.).

Reis Hansen (R)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Ahmed Abdelhaleem (A)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Yoko Mikami (Y)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Mingkai Peng (M)

Department of Medicine and Diagnostic Radiology, McGill University, Montreal, Canada (M.G.F.).

Sandra Rivest (S)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Alessandro Satriano (A)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Steven Dykstra (S)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Jacqueline Flewitt (J)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).

Bobak Heydari (B)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).
Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Canada (J.A.W., B.H., A.G.H.).
Department of Community Health Sciences, University of Calgary, Canada (M.P.).

Carmen P Lydell (CP)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).
Department of Diagnostic Imaging, Cumming School of Medicine, University of Calgary, Canada (J.A.W., C.P.L.).
Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Canada (J.A.W., B.H., A.G.H.).

Matthias G Friedrich (MG)

Department of Medicine and Diagnostic Radiology, McGill University, Montreal, Canada (M.G.F.).

Andrew G Howarth (AG)

Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (J.A.W., R.H., A.A., Y.M., S.R., A.S., S.D., J.F., B.H., C.P.L., A.G.H.).
Department of Community Health Sciences, University of Calgary, Canada (M.P.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH